VI
REGN icon

Vestcor Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Vestcor Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Hold
2,026
– – 0.03% 471
2026
Q1 		$1.56M Sell
2,026
-7
-0.3% -$5.36K 0.04% 386
2025
Q4 		$1.57M Hold
2,033
– – 0.04% 374
2025
Q3 		$1.14M Sell
2,033
-238
-10% -$135K 0.03% 436
2025
Q2 		$1.19M Sell
2,271
-3,756
-62% -$2.1M 0.04% 444
2025
Q1 		$3.82M Sell
6,027
-14,679
-71% -$10.1M 0.13% 172
2024
Q4 		$14.8M Sell
20,706
-884
-4% -$742K 0.49% 48
2024
Q3 		$22.7M Buy
21,590
+654
+3% +$728K 0.72% 25
2024
Q2 		$22M Sell
20,936
-79
-0.4% -$76.6K 0.74% 23
2024
Q1 		$20.2M Sell
21,015
-1,108
-5% -$1.05M 0.69% 29
2023
Q4 		$19.4M Sell
22,123
-1,200
-5% -$988K 0.66% 28
2023
Q3 		$19.2M Sell
23,323
-3,408
-13% -$2.68M 0.7% 30
2023
Q2 		$19.2M Buy
26,731
+3,069
+13% +$2.37M 0.7% 28
2023
Q1 		$19.4M Sell
23,662
-5,406
-19% -$4.08M 0.71% 27
2022
Q4 		$21M Sell
29,068
-9,069
-24% -$6.69M 0.77% 23
2022
Q3 		$26.3M Sell
38,137
-1,610
-4% -$1.01M 0.99% 12
2022
Q2 		$23.5M Sell
39,747
-1,451
-4% -$943K 0.87% 18
2022
Q1 		$28.8M Sell
41,198
-1,114
-3% -$705K 0.99% 12
2021
Q4 		$26.7M Buy
42,312
+1,885
+5% +$1.16M 0.94% 15
2021
Q3 		$24.5M Buy
40,427
+1,743
+5% +$1.08M 0.88% 17
2021
Q2 		$21.6M Buy
38,684
+12,922
+50% +$6.55M 0.73% 20
2021
Q1 		$12.2M Buy
25,762
+2,821
+12% +$1.37M 0.46% 47
2020
Q4 		$11.1M Buy
22,941
+1,083
+5% +$585K 0.46% 54
2020
Q3 		$12.2M Buy
21,858
+446
+2% +$270K 0.57% 38
2020
Q2 		$13.4M Buy
21,412
+19,701
+1,151% +$11.2M 0.69% 28
2020
Q1 		$835K Buy
1,711
+326
+24% +$134K 0.05% 342
2019
Q4 		$520K Buy
+1,385
New +$466K 0.02% 469

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Vestcor Inc's REGN Position: Q2 2026 in Review

Vestcor Inc held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 2,026 shares worth $1.26M. The position accounts for 0.03% of the portfolio, ranked #471.

Vestcor Inc first reported a position in REGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $28.8M in Q1 2022. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Vestcor Inc held 2,026 shares of Regeneron Pharmaceuticals worth $1.26M as of Q2 2026.
  • Vestcor Inc left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.03% of Vestcor Inc's portfolio in Q2 2026, its #471 holding.
  • Vestcor Inc first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Vestcor Inc's Regeneron Pharmaceuticals position peaked at $28.8M in Q1 2022.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.